First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study
2005; Elsevier BV; Volume: 16; Issue: 6 Linguagem: Inglês
10.1093/annonc/mdi181
ISSN1569-8041
AutoresOlavo Feher, P Vodvářka, Jacek Jassem, G Morack, Suresh H. Advani, K. Khoo, Dinesh Chandra Doval, S. Ermisch, D. Roychowdhury, Michael A. Miller, Gϋnter von Minckwitz,
Tópico(s)Breast Cancer Treatment Studies
Referência(s)